tiprankstipranks
10x Genomics price target lowered to $23 from $35 at Citi
The Fly

10x Genomics price target lowered to $23 from $35 at Citi

Citi lowered the firm’s price target on 10x Genomics (TXG) to $23 from $35 and keeps a Buy rating on the shares post the Q3 report. The company lowered the fiscal 2024 guide by $50M at the midpoint, implying flat sequential revenue in Q4, well below consensus, the analyst tells investors in a research note. The firm says weakness in the quarter was largely attributed to disruptions driven by commercial and organizational changes on top of challenging macro conditions.

Don't Miss our Black Friday Offers:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App